Furthermore, Phoenix WinNonlin includes the capability for user-defined parameters, and organizations can set strict criteria for the calculation of the terminal slope in NCA. The upgraded NCA engine automatically outputs additional NCA parameters for plasma and urine to save time, reduce errors, and provide higher transparency for regulatory agencies. The Most Comprehensive Set of Analysis Tools for Non-clinical and Clinical PK/PD Study From early non-clinical research to large clinical trials, Phoenix WinNonlin’s NCA engine, individual PK/PD modeling engine, and statistical analysis tools can be used for a wide-range of studies and analyses. Regulatory agencies, including 11 divisions of the US Food and Drug Administration (FDA), Japan Pharmaceutical and Medical Device Agency (PMDA), China Food and Drug Administration (CFDA), and the UK Medicines and Healthcare Products Regulatory Agency (MHRA), use Phoenix WinNonlin to evaluate drug submissions. Trusted by Scientists and Regulators around the Globe With a proven 30-year global history, Phoenix WinNonlin is used by over 6,000 scientists at more than 1,500 institutions in 60 countries, including the top pharmaceutical companies and 200 academic institutions.

Integrated tools for data processing, post-analysis processing, table creation, and graphics create an all-in-one collaboration workbench used by scientists, reviewers, medical writers, and quality assurance staff for drug development projects.

El Secreto De Lorenzo Hortense Ullrich Pdf. Outsource PK/PD Analysis and Clinical Study Report Writing Training A variety of courses teaching Pharsight software tools and model-based drug development. Phoenix WinNonlin: The Industry Standard for NCA and PK/PD Modeling and Simulation Phoenix ® WinNonlin ® is the industry standard for non-compartmental analysis (NCA), pharmacokinetic/pharmacodynamic (PK/PD), and toxicokinetic (TK) modeling.

Winnonlin trial download